Confluence Investment Management LLC Trims Stock Position in Gilead Sciences, Inc. $GILD

robot
Abstract generation in progress

Confluence Investment Management LLC reduced its stake in Gilead Sciences (NASDAQ:GILD) by 4.5% in the fourth quarter, now holding 909,835 shares worth approximately $111.7 million, making it their 19th largest holding. Despite this, institutional investors collectively own 83.67% of the company, and Wall Street analysts generally maintain a positive outlook with a “Moderate Buy” rating and a consensus target price of $157.62. The article notes mixed shareholder signals, including a dividend increase but also significant insider selling.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin